MedPath

Dopamine, stress reactivity & hearing impairment.

Conditions
psychosisstresshearing impairmentpsychoseslechthorendheid
Registration Number
NL-OMON26246
Lead Sponsor
Maastricht University
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Completed study NL24257.018.08.

Exclusion Criteria

N/A

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relationship between hearing impairment and reactivity (changes in affect and psychotic symptoms) to self-reported stress in daily life, assessed using the Experience Sampling Method (ESM).
Secondary Outcome Measures
NameTimeMethod
1. Association between dopamine release and stress reactivity;<br /><br>2. Group level differences in reactivity to other forms of (event related, activity) stress;<br /><br>3. Additional parameters measured: IQ (non-verbal), non-clinical psychotic symptoms, depression score, discrimination, perception of living environment, childhood care and abuse, life events, bullying, perceived effects of stigma. Also data from study NL24257.018.08.; self-other schemas, childhood trauma, social defeat score, family structure, SES, urbanicity, self-esteem, drug-use.
© Copyright 2025. All Rights Reserved by MedPath